Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, Zeng Z, Xiong W. · 2018
Read Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. by Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, Zeng Z, Xiong W. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5817860.txt.
Description
Zhang and co-authors detail the c-Met receptor and its cancer roles. C-Met sits on cell surfaces and answers to hepatocyte growth factor. In healthy tissue, that pairing guides embryo growth and wound repair. In tumors, it often runs out of control.
Faults arise from mutation, excess copies, or simple overproduction. Firing spreads through PI3K/AKT, Ras/MAPK, and Wnt pathways. Those signals push tumor growth, spread, and vessel feeding. C-Met also talks with RON and EGFR, two kin. The review closes with drugs that block c-Met in trials. Readers get the structure, the signals, and the treatment chase in one place.
Catalog record
| CREATOR | Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, Zeng Z, Xiong W. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |